Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04273893 · ClinicalTrials.gov registry record · NA
Lymphocyte Depletion and Change in Lymphocyte Functionality
A NA study of Lymphocyte Depletion, sponsored by University of Virginia.
- Active
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT04273893 is a NA study of Lymphocyte Depletion that is active but no longer recruiting, run by University of Virginia. The registered enrollment target is 55 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04273893, a NA study of Lymphocyte Depletion, is active but no longer recruiting, sponsored by University of Virginia.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
Lymphocytes are a type of white blood cell (WBC) responsible for adaptive immunity. Thoracic tumors are adjacent to many blood/immune rich organs including the great vessels, heart, thoracic-spine, and lymph-node-stations. During radiation treatment the impact to lymphocytes can be significant. This may cause a decrease in the amount of lymphocytes. A researcher at UVA has created a system to predict and reduce the immune cell reduction following lung SBRT treatments beyond standard of care. The predicted decrease in lymphocytes will be compared to the actual decrease in lymphocytes found in peripheral blood. Researchers have found a way to give radiation that they think will result in a smaller decrease in lymphocytes after radiation. There will be two groups in this study, about half of the participants will have their radiation designed to decrease radiation to organs with a lot of blood and the other half will receive standard radiation therapy. Participants are being asked to take part in this study because the participants have been diagnosed with NSCLC and will be receiving a type of radiation therapy called stereotactic body radiation therapy (SBRT) where high doses of radiation will be delivered to the tumor, while minimizing damage to healthy surrounding tissues.
Conditions Studied
Interventions
- RADIATION SBRT with additional treatment planning dose optimization
- RADIATION SBRT with standard of care planning only
- DIAGNOSTIC_TEST Blood Draws
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2020-02-12 |
| Est. Completion | 2025-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04273893
The ClinicalTrials.gov registry entry for NCT04273893 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lymphocyte Depletion appearing as the primary indexed condition, and to 3 interventions - of which SBRT with additional treatment planning dose optimization is the first listed.
NCT04273893 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT04273893 about?
NCT04273893 is a clinical study titled "Lymphocyte Depletion and Change in Lymphocyte Functionality". Lymphocytes are a type of white blood cell (WBC) responsible for adaptive immunity. Thoracic tumors are adjacent to many blood/immune rich organs including the great vessels, heart, thoracic-spine, and lymph-node-stations. During radiation treatment the impact to lymphocytes can be significant. This...
What is the current status of trial NCT04273893?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 55 participants. The study started on 2020-02-12. Estimated completion is 2025-06-01.
What conditions does trial NCT04273893 study?
This clinical trial studies the following conditions: Lymphocyte Depletion.
What interventions are being tested in trial NCT04273893?
The interventions under investigation include: SBRT with additional treatment planning dose optimization (RADIATION), SBRT with standard of care planning only (RADIATION), Blood Draws (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04273893?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04273893 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.